Myelitis - 118 Studies Found
| Completed |
: Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months : Poliomyelitis : 2017-01-16 :
|
| Completed |
: Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan :
: 2013-12-03 : Biological: IMOVAX POLIO®: Inactive Poliovirus Vaccine 0.5 mL, Subcutaneous |
| Completed |
: Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly : Poliomyelitis : 2008-01-17 :
|
| Completed |
: Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly : Poliomyelitis : 2009-04-20 :
|
| Completed |
: 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants : Poliomyelitis : 2015-01-15 :
|
| Completed |
: Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine : Poliomyelitis : 2016-05-25 : Biological: poliovirus vaccine Different vaccination schedules with bOPV, tOPV and cIPV would be provide |
| Completed |
: Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults : Poliomyelitis : 2012-10-15 :
|
| Completed |
: Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV :
: 2006-07-03 :
|
| Completed |
: Safety and Immunogenicity of IPOVAC in Young Children : Poliomyelitis : 2016-05-05 :
|
| Not yet recruiting |
: Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) :
: 2015-10-27 :
|